Retenir
NOS SERVICES Portefeuille TRADER Portefeuille INVESTISSEUR Portefeuille INTERNATIONAL TRADING MANAGER CONCOURS BOURSIER
 
Rechercher
Cotations dynamiques   
On
 | Off

Accueil Zonebourse  >  Actions  >  NYSE  >  ABBOTT LABS   ABT   US0028241000

ABBOTT LABS (ABT)

Cours en différé. Temps Différé - 05/09 22:00:20 
57.01 USD   +0.78%
16/07 | 14:59 Relève son objectif de BPA pour 2008.
16/04 | 14:59 Résultats en forte hausse au T1, objectifs confirmés
23/01 | 15:10 Améliore ses résultats au 4è trimestre.
SynthèseCotationsAnalyse graphiqueActualitésAgendaSociétéFondamentauxConsensusPositionsDérivésForum
Synthèse actualitéToute l'actualitéRecommandations des analystesAnalyses ZonebourseInterviewsActualités RSS

Abbott Labs : SectorWatch.biz Issues MarketStats on KBLB, DGX, LH, BRLI, and ABT

23/04/2008 | 15:00

IRVINE, Calif., April 23 /PRNewswire/ -- SectorWatch.biz announces the availability of MarketStats on public equities in the news and driving markets today within the biotechnology and diagnostic testing arena. MarketStats offers a perspective on the aforementioned equities and the opportunity for investors to respond with articles and opinions on the subject and sector.

Investors can view SectorWatch.biz MarketStats by visiting: http://www.SectorWatch.biz -- a division of financial news hub SmallCapSentinel.com

Today's MarketStats on diagnostic companies include: Kraig Biocraft Laboratories, Inc. (OTC Bulletin Board: KBLB), Quest Diagnostics Inc. (NYSE: DGX), Laboratory Corp. of America Holdings (NYSE: LH), Bio-Reference Laboratories Inc. (NasdaqGS: BRLI) and Abbott Laboratories (NYSE: ABT).

To view a complete StockUpTicks.com profile on Kraig Biocraft Laboratories, Inc. visit http://stockupticks.com/profiles/3-10-08.html

Visit SectorWatch's parent site SmallCapSentinel.com for a Biotechnology message board and to read or contribute articles on the subject. Users are invited to post editorials and messages on the website. Intelligent articles submitted through the site will be posted as Member Editorials for review by the investing public. http://smallcapsentinel.com/stock/healthcare-biotechnology/biotechnology%3A- research-therapeutics-discovery (Please copy and paste into your web browser)

MarketStats provide snapshots and analysis on public equities making news, driving industry sectors and affecting the markets. SectorWatch.biz is powered by Market Pathways, a leader in the representation of Small Cap equities for over twenty-five years and your discovery zone for under-followed stocks emerging in the market.

Interested investors may subscribe to our StockUpTicks newsletter featuring a treasure trove of promising companies, daily market movers and free personal investment information -- visit http://stockupticks.com/register.html. D.R. Clark of Market Pathways is a member of the National Association of Securities Dealers, CRD # 4518163.

Contact us directly to have your company featured in StockUpTicks.com or SectorWatch.biz. For D.R. Clark's perspective on personal finance and the markets visit http://www.ClarkReport.com

Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results. SectorWatch.biz and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience. The subject companies have not always approved the statements made in this report.

This report is neither a solicitation to buy nor an offer to sell securities but is for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor, analyst or licensed broker dealer and this report is not investment advice. MP has been paid thirty thousand dollars by Kraig Biocraft Laboratories, Inc. for preparation and distribution of this report and other services over a ninety day period. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject company.

SOURCE SectorWatch.biz

Dernières actualités sur ABBOTT LABS
16/07 | 14:59 Relève son objectif de BPA pour 2008.
16/04 | 14:59 Résultats en forte hausse au T1, objectifs confirmés
23/01 | 15:10 Améliore ses résultats au 4è trimestre.
12/07 | 08:05 N'est pas arrivé à un accord avec GE.
24/01 | 15:54 A dépassé ses prévisions au 4T.
18/10 | 15:07 Vise un bpa 4T de 73 à 75 cents.
18/10 | 15:03 Bénéfice net en hausse de 5% au 3T.
08/09 | 15:52 331ème dividende trimestriel consécutif
Graphique de news
Court termeMoyen termeLong terme

Actualités

Fermer

Actualité

Fermer
Mes valeurs 
- Liste vide -
>> Devenez membre, c’est gratuit
   
Qui sommes nous ?   |   Contact   |   Avertissement légal    |   Recrutement   |   Devenir membre   |   Devenir client   |   
Graphiques Dynamiques : IT Finance / GL  |  Analyse Fondamentale : Combho SAS CIF N°D007078 membre CNCIF agréée AMF  |  Fondamentaux et Consensus : Cofisem, Reuters
Actualités : Dow Jones Newswires, Reuters, Lesechos.fr, Cercle Finance, Abcbourse.com, Investir.fr, Agpresse, Company News, Actusnews et Business Wire.
Cotations bourses NyseEuronext, Nasdaq en différé de 15 minutes, Indices Nasdaq et Dow Jones en provenance de Dow Jones & Company sont en différé de 15 minutes,
Indice CAC 40 en temps réel, bourse Tradegate et devises en Temps réel. Autres bourses et indices en fin de journée. Source : Interactive Data -Tijd Beursmedia
Copyright ©  2001- 2008 Surperformance SAS /